Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether positron emission tomography / computed
tomography (PET/CT) using fluorine-18 fluorocholine as an imaging agent can characterize
regional responses to anti-androgen therapies in a manner that in the future aid in the
customized planning of treatments for patients with androgen-insensitive prostate cancer.